Sanofi-Aventis has made a series of changes within its top-level executive ranks, including the appointment of Jean-Pierre Lehner, MD, as chief medical officer; Laurence Debroux as chief strategic officer; and named Elias Zerhouni, MD, as scientific advisor to its CEO Christopher A. Viehbacher and to its senior vice president of research and development, Marc Cluzel.